Advanced Search

 

Study ID Status Title Patient Level Data
US22 Completed An evaluation of the dose proportionality and bioequivalence of LAMICTAL® tablets in normal volunteers.
US47 (105-047) Completed A pilot bioequivalence study of US and UK manufactured 100 mg LAMICTAL® (lamotrigine) dispersible/chewable tablets in normal healthy volunteers.
US50 Completed Repeated bioequivalence study of US 25 mg Lamictal® compressed tablets, US 5 mg Lamictal® dispersible/chewable tablets and UK 5 mg Lamictal® dispersible/chewable tablets in healthy adult male volunteers.
USA30206 Completed A randomised, double-blind, parallel group, multi-centre study comparing the safety and efficacy of a remifentanil and propofol regimen versus a fentanyl and propofol regimen, including an investigation of the pharmacokinetics of remifentanil and remifentanil acid, in Intensive Care Unit patient ...
USA30207 Completed A randomised, double-blind, parallel group, multi-centre study comparing the safety and efficacy of a remifentanil and midazolam regimen versus a morphine and midazolam regimen in Intensive Care Unit patients requiring analgesia and sedation in association with short-term mechanical ventilation.
USA30212 Completed An open label, non-comparator, multi-centre study to assess the safety, efficacy and pharmacokinetics of remifentanil in Intensive Care Unit patients with varying degrees of renal dysfunction requiring analgesia and sedation in association with mechanical ventilation.
USA30217 Completed A Randomised, open, multicentre, parallel group study comparing the safety and efficacy of an Ultiva (remifentanil HCL) + propofol/midazolam regimen versus fentanyl + propofol/midazolam or morphine + propofol/midazolam regimens in mechanically ventilated intensive care unit subjects with brain i ...
USA30225 Completed An economic evaluation of an analgesia-based sedation regimen with remifentanil supplemented with propofol compared to a conventional sedation regimen with midazolam/fentanyl in the ICU for patients after cardiac surgery
USA30226 Completed A randomised, open-label, multicentre, parallel group study comparing the safety and efficacy of an Ultiva (remifentanil hydrochloride) based analgesia/sedation regimen with a conventional sedative-based regimen in long-term ICU subjects requiring analgesia and sedation for up to 10 days. Study Listed on ClinicalStudyDataRequest.com
USA30229 Completed A randomized, open-label, multicentre study comparing the safety and efficacy of a remifentanil + propofol sedoanalgesia regimen versus morphine + propofol regimen in Intensive Care Unit mechanically ventilated patients with medical pathology.
USA40036 Completed A randomised, single-blinded study to evaluate the efficacy and safety of remifentanil versus sufentanil in patients undergoing coronary artery bypass graft surgery and/or valve surgery
V7341104 Completed A Dose-Ranging Study to Evaluate the Pharmacokinetics and Pharmacodynamics of a Sleep Aid
VALF1004 Completed Safety Follow-Up of the Association Valaciclovir –Tacrolimus and Evaluation of the Potential Pharmacokinetic Interaction Between Valaciclovir and Tacrolimus When They are Co-Administered in Renal Transplant Recipients
VALF1005 Completed Safety Follow-Up of the Association Valaciclovir-Mycophenolate Mofetil and Evaluation of the Potential Pharmacokinetic Interaction Between Valaciclovir and Mycophenolate Mofetil When They are Co-Administered in Renal Transplant Recipients
VALF1007 Completed A pharmacokinetic study to evaluate the intra-ocular penetration of aciclovir following single, oral dose of valaciclovir in subjects undergoing cataract surgery.
VALF3002 Completed Multicentre, randomised, open-label study to compare the efficacy and safety of valaciclovir oral route and aciclovir intravenous route, to treat zoster in immunodeficient patients.
VAL-R19 Completed A Single-Center, Open-Label Study of the Safety and Pharmacokinetics of Valacyclovir in Children with Epstein-Barr Virus Illness Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
VAL-R56 Completed Acyclovir Concentrations in Human Breast Milk After Valaciclovir Administration. Extensive searching has revealed that no clinical study report is available for this study.
VALR94 Completed An Open-Label Pilot Study of valacyclovir (VALTREX) 2000 mg BID for One Day in the Episodic Treatment of Recurrent Genital Herpes
VEG10003 Completed A Phase I, Open-Label, Multiple Dose, Dose Escalation Study of GW786034 in Patients with Solid Tumors
VEG10004 Completed An Open-Label, Two-Part Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of Pazopanib (GW786034) and the Absorption, Distribution, Metabolism and Elimination of a Single Oral [14C] Labeled Dose of Pazopanib in Subjects with Solid Tumor Malignancies
VEG10005 Completed An Open-Label, Two-Period, Randomized, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Single Doses of Pazopanib in Cancer Patients
VEG10006 Completed An Open-Label, Safety, Pharmacokinetic and Pharmacodynamic Study of Multiple Doses of GW786034 and Lapatinib Concomitantly Administered in Cancer Patients.
VEG10007 Completed A Multi-center, Open-Label, Multiple-probe Drug Interaction Study to Determine the Effects of GW786034 on the Metabolism of Cytochrome P450 Probe Drugs in Patients with Solid Tumors
VEG102616 Completed A Phase II Study of GW786034 Using a Randomised Discontinuation Design in Subjects with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.